Interphase cytogenetic studies of human hepatocellular carcinomas by fluorescent in situ hybridization

• Published in: Hepatology (Baltimore, Md.) Vol. 23; no. 3; pp. 429 - 435
• Main Authors: Hamon-Benais, C, Ingster, O, Terris, B, Couturier-Turpin, M, Bernheim, A, Feldmann, G
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.03.1996
• ISSN: 0270-9139; 1527-3350
• DOI: 10.1053/jhep.1996.v23.pm0008617421

Although numerous allelic chromosome losses have been reported in hepatocellular carcinomas (HCC), chromosome analysis by cytogenetic methods has rarely been performed in these tumors, unlike other solid malignant tumors. The purpose of the current study was to analyze primary liver tumors by conventional cytogenetic methods and by a new molecular cytogenetic technique, called fluorescent in situ hybridization (FISH), a technique that has been recently proposed to count the number of chromosome copies in interphase nuclei with chromosome centromeric probes. Primary cultures of tumoral cells were prepared to obtain metaphases. Specific chromosomes probes 7, 17, and 20 were used to perform in situ hybridization on isolated intact tumoral cells. Seven cases of primary liver tumors (six cases of HCC and one case of benign focal hepatic nodular hyperplasia) were investigated. A few metaphases were obtained in five of the seven tumors, and in most cases numerical abnormalities were difficult to interpret. In contrast with in situ hybridization, all cases of HCC showed losses and/or gains of chromosomes. Loss of one to three chromosomes occurred in five tumors. A gain of two chromosomes was observed in two of these five tumors. In only one case, a gain of only three chromosomes occurred. In addition, a loss of chromosome 17 was recorded for the benign tumor. These results demonstrate that FISH with specific probes can provide information on chromosome number in the tumoral cells of primary liver tumors even in the absence of analyzable metaphases. This technique opens new possibilities for the investigation of chromosome abnormalities in HCC. (Hepatology 1996 Mar;23(3):429-35)